CStone Pharmaceuticals carries a market capitalization of 1.14B, placing it among publicly traded companies globally.
| Market Cap | 1.14B |
| Enterprise Value | N/A |
CStone Pharmaceuticals's stock has gained approximately 13.6% over the past 52 weeks. The 50-day moving average sits at 0.76, while the 200-day moving average is 0.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.6% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 0.86 |
| Average Volume (20 Days) | N/A |